Literature DB >> 2842410

Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier.

T Terasaki1, W M Pardridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2842410     DOI： 10.1093/infdis/158.3.630

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  15 in total

Review 1.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.

Authors:  Tetsuya Terasaki; Sumio Ohtsuki
Journal:  NeuroRx       Date:  2005-01

2.  Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis.

Authors:  N Borg; L Ståhle
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis.

Authors:  S L Wong; Y Wang; R J Sawchuk
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

4.  Evaluation of a brain-targeting zidovudine chemical delivery system in dogs.

Authors:  M E Brewster; W R Anderson; A I Webb; L M Pablo; D Meinsma; D Moreno; H Derendorf; N Bodor; E Pop
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue.

Authors:  R H Lupia; N Ferencz; J J Lertora; S K Aggarwal; W J George; K C Agrawal
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 6.  Zalcitabine. Clinical pharmacokinetics and efficacy.

Authors:  D Devineni; J M Gallo
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

7.  In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.

Authors:  R Masereeuw; U Jaehde; M W Langemeijer; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.

Authors:  T Tuntland; R J Ravasco; S al-Habet; J D Unadkat
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

Review 9.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 10.  Didanosine, a new antiretroviral drug. A review.

Authors:  R M Franssen; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.